Document Detail


Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?
MedLine Citation:
PMID:  23286853     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The current standard of care (SOC) for patients with chronic HCV genotype 1 is a combination of either boceprevir or telaprevir with peginterferon (PEG-IFN) and ribavirin (RBV). Although it is effective in a high percentage of patients, this treatment is associated with significant adverse events (AEs). The next generation of protease inhibitors, simeprevir and faldaprevir, will also be used with PEG-IFN/RBV. Interferon-free therapy with sofosbuvir appears promising and on the horizon for patients with genotypes 2 and 3, but may still be many years away for patients with HCV genotype 1. The factors which should be considered when deciding whether to treat a patient with HCV and mild fibrosis with the current SOC now, or to delay treatment until less toxic and/or more effective therapy is available is discussed.
Authors:
Mitchell L Shiffman; Yves Benhamou
Related Documents :
23873153 - Effects of antiretroviral therapy on arterial stiffness in cameroonian hiv-infected pat...
23110113 - Survival among patients with hiv infection and smear-negative pulmonary tuberculosis - ...
21929723 - Hiv testing and antiretroviral treatment strategies for prevention of hiv infection: im...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  33 Suppl 1     ISSN:  1478-3231     ISO Abbreviation:  Liver Int.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  105-10     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Affiliation:
Liver Institute of Virginia, Bon Secours Health System, Richmond and Newport News, VA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interferon free therapy with direct acting antivirals for HCV.
Next Document:  Impact of therapy on the outcome of chronic hepatitis B.